Ambeed.cn

首页 / / / / Levamisole/左旋咪唑

Levamisole/左旋咪唑 {[allProObj[0].p_purity_real_show]}

货号:A176170 同义名: 左旋咪唑碱 / (-)-Tetramisole

Levamisole是一种免疫调节剂,作为碱性磷酸酶的竞争性抑制剂,能够调节免疫反应,促进免疫系统的功能。它被广泛应用于增强免疫活性,并有应用于复发性疱疹感染研究领域的潜力。

Levamisole/左旋咪唑 化学结构 CAS号:14769-73-4
Levamisole/左旋咪唑 化学结构
CAS号:14769-73-4
Levamisole/左旋咪唑 3D分子结构
CAS号:14769-73-4
Levamisole/左旋咪唑 化学结构 CAS号:14769-73-4
Levamisole/左旋咪唑 3D分子结构 CAS号:14769-73-4
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Levamisole/左旋咪唑 纯度/质量文件 产品仅供科研

货号:A176170 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Levamisole/左旋咪唑 生物活性

描述 Levamisole is an anthelmintic agent with immunomodulatory effects[1]. Treatment of human dendritic cells with 1 μM levamisole significantly promoted the secretion of IL-12 p40 and IL-10 secretion compared to the control group. Levamisole at 1 μM also further enhanced lipopolysaccharide (10 ng/mL)-induced production of IL-12 p40 and IL-10 in human dendritic cells. Levamisole-treated dendritic enhanced T cell activation towards type 1 cytokine balance. The NF-κB and JNK pathways were involved in levamisole-induced secretion of IL-12 p40 in dendritic cells[2]. In mice infected with 1,000 infective T canis larvae, subcutaneous administration of levamisole hydrochloride at a dose of 12 mg/kg/day from days 15 to 28 of infection decreased the infection in all organs[3].
作用机制 Levamisole exerts its immunomodulatory effects through cholinergic activity on T lymphocytes, resulting in an increase in the level of cyclic guanosine monophosphate in lymphocytes[1].

Levamisole/左旋咪唑 细胞实验

Cell Line
Concentration Treated Time Description References
AS MSCs 100 μM Inhibition of accelerated mineralization in AS MSCs J Clin Invest. 2019 Dec 2;129(12):5357-5373
CD4+CD25-T cells 8 mg/ml, 40 mg/ml, 200 mg/ml 72 hours suppressed T cell proliferation Front Immunol. 2022 Jul 14;13:907808
DC2.4 cells 8 mg/ml, 40 mg/ml, 200 mg/ml 48 hours inhibited TLR7 agonist-induced proinflammatory cytokine production Front Immunol. 2022 Jul 14;13:907808
BMNCs (bone marrow nucleated cells) 40 mg/ml 48 hours downregulated genes related to APCs and T cells Front Immunol. 2022 Jul 14;13:907808
Regulatory T cells (Tregs) 8 mg/ml, 40 mg/ml, 200 mg/ml 72 hours increased the proportion of Tregs Front Immunol. 2022 Jul 14;13:907808
vascular smooth muscle cells (VSMCs) 200 μmol/L The combination of TNAP inhibitor levamisole and eNTPD inhibitor ARL67156 increased extracellular pyrophosphate synthesis in LmnaG609G/ +VSMCs 2-fold, reduced pyrophosphate hydrolysis by 91%, and decreased calcium accumulation by 92%. Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23698-23704
Human microvascular endothelial cells (HMVECs) 100 μg 24 hours To assess the cytotoxic effects of Levamisole-induced NETs on endothelial cells. Results showed that Levamisole-induced NETs significantly enhanced endothelial cell apoptosis. JCI Insight. 2017 Feb 9;2(3):e89780
Peripheral blood neutrophils from healthy human subjects 100 μM 3 hours To evaluate the effect of Levamisole on neutrophil extracellular trap (NET) formation. Results showed that Levamisole significantly increased NET formation, which was dependent on the activation of NADPH oxidase and PAD4. JCI Insight. 2017 Feb 9;2(3):e89780

Levamisole/左旋咪唑 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
CB6F1 mice Immune-mediated bone marrow failure model Oral 20 mg/kg Once daily starting from day 0 until the mice died Improved pancytopenia and prolonged survival, suppressed effector T cells and promoted regulatory T-cell expansion Front Immunol. 2022 Jul 14;13:907808
Mice LmnaG609G/ +mouse model Intraperitoneal injection 0.2 mg/kg Every 2 days, starting from 8 weeks of age until death or euthanasia Combined treatment with ATP, levamisole, and ARL67156 significantly extended the lifespan of LmnaG609G/ +mice (from 38.2 to 42.8 weeks, 11.9%) and reduced aortic calcification (from 837.4 ±189.7 μg/g to 443.9±76.3 μg/g). Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23698-23704
Mice Aortic ring model In vitro culture 100 μg 15 minutes To evaluate the effect of Levamisole-induced NETs on vascular relaxation. Results showed that Levamisole-induced NETs significantly impaired endothelium-dependent vasorelaxation. JCI Insight. 2017 Feb 9;2(3):e89780
Swiss albino male mice Immunomodulatory activity evaluation model Oral 50 mg/kg 14 days Evaluate the immunomodulatory effects of Levamisole in mice, results showed Levamisole significantly increased thymus index (p<0.001). Immunotargets Ther. 2024 Jan 23;13:15-27
BALB/c male mice Cyclophosphamide-induced immunosuppressed mouse model Oral gavage 10 mg/kg Continuous for 28 days To evaluate the immunomodulatory effects of levamisole hydrochloride on immunosuppressed mice. The results showed that levamisole hydrochloride significantly improved immune organ atrophy, restored intestinal morphology, and normalized cytokine levels, indicating enhanced immune function. Front Immunol. 2025 Jan 27;16:1513531

Levamisole/左旋咪唑 参考文献

[1]Scheinfeld N, Rosenberg JD, Weinberg JM. Levamisole in dermatology : a review. Am J Clin Dermatol. 2004;5(2):97-104. doi: 10.2165/00128071-200405020-00004

[2]Chen LY, Lin YL, Chiang BL. Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells. Clin Exp Immunol. 2008 Jan;151(1):174-81. doi: 10.1111/j.1365-2249.2007.03541.x

[3]Carrillo M, Barriga OO. Anthelmintic effect of levamisole hydrochloride or ivermectin on tissue toxocariasis of mice. Am J Vet Res. 1987 Feb;48(2):281-3

Levamisole/左旋咪唑 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.90mL

0.98mL

0.49mL

24.48mL

4.90mL

2.45mL

48.95mL

9.79mL

4.90mL

Levamisole/左旋咪唑 技术信息

CAS号14769-73-4
分子式C11H12N2S
分子量 204.29
SMILES Code C12=N[C@@H](C3=CC=CC=C3)CN1CCS2
MDL No. MFCD00792481
别名 左旋咪唑碱 ;(-)-Tetramisole
运输蓝冰
InChI Key HLFSDGLLUJUHTE-SNVBAGLBSA-N
Pubchem ID 26879
存储条件

In solvent -20°C:3-6个月-80°C:12个月

溶解方案

DMSO: 105 mg/mL(513.97 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。